All in all, the results are better than expected and convincing.
All of the company's business segments have contributed strongly to the earnings improvement, which shows that the past years' efforts to improve efficiency have paid off.
Bayer has now manifest its will to move forward. This is positive because now we know they can stick to their time frame.
I think Engelhard is opening up to a friendly transaction.
If the final price comes in over $40 per share, we would consider this negative.
It's clearly BASF's strategic thinking not to give in and raise the price unless they get some information that justifies it.
Strengthening their product range further down the value chain makes a lot of sense.
The company's salt acquisitions are paying off big time thanks to the winter weather.
The pain threshold is around $40. They can't go a lot over $40 without the capital markets seeing that negatively. There is a point where a price would not justify the transaction.
The results were in line. The chemicals cycle is humming right now. The high dividend is not surprising, seeing the growth in profit.
This is a good amendment of Bayer's cardiology and hematology portfolio.
This is a good building block for Bayer.
This is a real setback.
This move comes as a surprise, but BASF so far has an excellent track record in acquisitions that were always adding value to investors.
Diese Website konzentriert sich auf Sprichwörter der schwedischen Sprache. Einige Teile einschließlich der Links sind nicht ins Deutsche übersetzt worden. Diese Links sind hauptsächlich FAQ, verschiedene Informationen und Webseiten, die der Erweiterung der Sammlung dienen.
Diese Website konzentriert sich auf Sprichwörter der schwedischen Sprache. Einige Teile einschließlich der Links sind nicht ins Deutsche übersetzt worden. Diese Links sind hauptsächlich FAQ, verschiedene Informationen und Webseiten, die der Erweiterung der Sammlung dienen.